Stoke Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
21.65 | 48.72 | -55.56% | -7.15 | -402.82% |
| P/S |
|
26.36 | 33.75 | -21.91% |
|
|
| P/BV |
|
1.45 | 4.82 | -69.9% |
|
|
| P/FCF |
|
-2.93 | 61 | -104.81% |
|
|
| Ev/Ebitda |
|
-0.4253 | -22.17 | -98.08% |
|
|
| Ev/S |
|
5.33 | 22.56 | -76.37% |
|
|
| Ev/FCF |
|
-0.5661 | 68.75 | -100.82% |
|
|
| E/P |
|
-0.4317 | 0.0178 | -2528.87% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1253.35 | 4.98 | -25283.12% | -1658.9 | -24.45% |
| ROE |
|
-65.62 | 9.61 | -782.67% |
|
|
| ROA |
|
-45.85 | 0.3443 | -13418.98% |
|
|
| ROIC |
|
-36.34 | 7.63 | -576.01% |
|
|
| ROS |
|
-1192.47 | -25.17 | 4637.64% |
|
|
| ROCE |
|
-71.93 | 15.35 | -568.58% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0621 | -3.68 | -98.31% | -0.0366 | +69.48% |
| Nеt Debt/Ebitda |
|
1.68 | -3.44 | -148.81% |
|
|
| Debt/Ratio |
|
0.0299 | 0.1985 | -84.92% |
|
|
| Debt/Equity |
|
1.02 | 1.66 | -38.63% |
|
|
| Debt/Net Income |
|
-0.0653 | 10.32 | -100.63% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
192.67 | -56.89 | -438.67% | ||
| Growth impulse Ebitda in 5 years |
|
218.79 | -54.68 | -500.13% | ||
| Growth impulse Net Income in 5 years |
|
227.18 | -58.33 | -489.47% | ||
| Growth impulse FCF in 5 years |
|
150.55 | -49.48 | -404.26% | ||
| Growth impulse EPS in 5 years |
|
32.21 | -32.41 | -199.38% |
IP Score
4.78/10
